(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

MÉTODO PARA REDUZIR NEUTROPENIA

IndeferidaInvention PatentPCT · US2018016498

Application data

Number

112019015974

Type

Invention Patent

Filing

02/01/2018

Publication

03/31/2020

PCT

US2018016498

Progress at the INPI

Under appeal
  1. Filing02/01/18
  2. Publication03/31/20
  3. Examination
  4. Refused04/08/25
  5. Grant
  6. In force

The application was refused by the INPI on 04/08/2025. The invention was never patented.

Talk to a specialist

Latest action published by the INPI: 04/08/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

BEYONDSPRING PHARMACEUTICALS, INC.

US

See this company's full portfolio

Inventors

G. L. (pessoa física)

US

L. H. (pessoa física)

US

R. M. (pessoa física)

US

Technical data

Priority claims

US

62/453,375 · 02/01/2017

US

62/621,533 · 01/24/2018

Abstract

São divulgados aqui plinabulina e o uso para reduzir neutropenia. Algumas modalidades se referem a reduzir a neutropenia induzida por docetaxel usando plinabulina.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Indeferimento

#9.2

04/08/2025

RPI 2831

Conhecimento de parecer técnico

#7.1

12/17/2024

RPI 2815

Conhecimento de parecer técnico

#7.1

09/03/2024

RPI 2800

Parecer de pré-exame

#6.23

07/26/2022

RPI 2690

Adição na publicação

#15.35

10/13/2021

RPI 2649

Notificação de entrada na fase nacional - PCT

#1.3

03/31/2020

RPI 2569

Alteração de dados cadastrais

#1.1

08/13/2019

RPI 2536

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.